7/31/2019 DIL Inv.presentation May 12
1/38
Dabur India Limited
May 2012
11
7/31/2019 DIL Inv.presentation May 12
2/38
AgendaAgenda
Da bu r I n d i a- I n t r o d u ct i o n
FMCG Industry Scenario
Growth Strategy
Recent Performance
22
7/31/2019 DIL Inv.presentation May 12
3/38
Dabur India: OverviewDabur India: OverviewEsta is e in 1884 - more t an 125
Years of Trust & Excellence
Among top 4 FMCG companies in India
Worlds lar est in A urveda and natural
Tw elve Bi l l i on Rupee Brand s
healthcare
Revenue of Rs. 53.2 billion and profits ofRs. 6.4 billion in FY2011-12
Dabur is a household brand
Vatika and Real are Superbrands
Hajmola , Real & Dabur ranked amongIndias Most Admired Brands
12 Brands with sales of over Rs. 1 billioneach
Wide distribution network coverin 3.4
million retailers across the country
17 world class manufacturing plantscatering to needs of diverse markets
Dabur rankedas No. 2 MostSocial Brand ofIndia, in theSocial Media
Dabur rankedthe No. 2 IndianGreen Brand byGreen BrandsGlobal Survey
Dabur has beenranked as the MostTrusted Leader inthe Healthcarecategory in the
33
.contribution to consolidated sales
report launchedat Click AsiaSummit 2012
Brand Trust Report2012
Dabur has surpassed the US$ 1 billion mark in revenues
7/31/2019 DIL Inv.presentation May 12
4/38
Dabur: Vision and Core ValuesDabur: Vision and Core Values
Ded i ca ted t o t he hea l t h and w e l l be i ng o f ev e ry hou s eho ldVis ion
Ownersh ip
Pass ion fo rW i n n i n g
I n t e g r i t y
CoreValues
PeopleDeve lopment
I n n o v a t i o n
ConsumerTeam Wor k
44
ocus
7/31/2019 DIL Inv.presentation May 12
5/38
Key MilestonesKey Milestones
1 8 8 4
Dr. SK Burm ans ta r t ed an A yurved i cPharm acy i n K o lka t t a
1 9 7 2
The com panysh i f t ed base t oDe lh i f r om K o lka ta
1 9 8 6
Regis tered asPubl ic L imi t edCompany
1 9 9 4
L is ted on t h e
1 9 9 8
Profess iona l i zed w i th
2 0 0 3
Pharm aceut ica l Bus inessBomb ay StockExchange
B urman Fam i l y hand ingover day t om a n a g e m e n t
de-m erged t o f ocus on coreFMCG business
2 0 0 4
I n t e r n a t i o n a lBus iness set up inDuba i t o t ap ove rseaso p p o r t u n i t y
2 0 0 5
Acqui red Ba lsaras t reng th en ing Ora lcare & ga in ing en t r yi n to Hom e ca re
2 0 0 6
D ab u r Fi g u r e d i n To p10 Great P laces ToW o r k
2 0 0 8
Acqui red Fem Care
2 0 1 0
Overseas acqu is i t ions -Ho bi Gr ou , Tu r k ey an d
2 0 1 2
Cro ssed Rs. 50 bnm a r k i n a n n u a l
55
m a inst ream Sk in ca re Nam aste Laborat or ies , US revenues and Marke t
Cap of c . US$4 bi l l i on
7/31/2019 DIL Inv.presentation May 12
6/38
Dabur Consolidated : OverviewDabur Consolidated : Overview
52 83260000
Sales
in Rs. m i l l ion
12,004 12,849 12,356 14,17017,565 20,803
23,963 28,34134,158
40,774
0
10000
20000
30000
40000
50000
FY02 FY03 FY04^ FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12
EBI TDA Mar g in ( in % ) Net Pr o f i t
5 0325,686
6,449
6000
7000
17.1%18.1% 18.5% 18.3%
19.8%20.4%
17.90%20.0%
22.0%
in % in Rs . m i l l ion
1,0651,558
2,1422,817
3,3293,913
,
0
1000
2000
3000
4000
5000
13.3%
15.3%
10.0%
12.0%
14.0%
16.0%
.
66
FY04 FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12FY04 FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12
^ Sales show a decline in FY04 on account of de- merger of Pharm a business
7/31/2019 DIL Inv.presentation May 12
7/38
Global FootprintGlobal Footprint
Canada
UK
Turkey
U.S. Egypt
UAENepal
N ige r i a
BDesh
Dom est ic Mfg .Locat ions
Manufacturing Facilities
Key markets
77
Our s t r a tegy i s t o l oca l ize m anu fac tu r i ng , supp l y cha inand p r oduc t o f f e r i ngs t o su i t consumer r equ i r em en ts
i n each g eogr aphy
7/31/2019 DIL Inv.presentation May 12
8/38
Robust Distribution NetworkRobust Distribution Network
Factory
St ock ist Su p er St ock ist I n s t i t u t i o n s
t r a d e
W h o lesa ler s Su b St ock ist
RETAI L TRADE
CONSUMERS
88
Di rect + I nd i rec t Reach c ov e r i ng c . 3 . 4 m i l l ion re t a i l ou t l e t s
7/31/2019 DIL Inv.presentation May 12
9/38
Research & Development FocusResearch & Development Focus
St r on g New Pr oduc t Deve lopmen t
Ayur ved ic Medic ines
Personal Care
Team o f sc ien t i s t s i nc lud ingAyur ved ic doc tor s , Pharm ac ists ,Agron om is ts , Botan is ts , Ti ssueCul t u r e spec ia l i st s , e t c .
oo s
Hom e Care
OTC HealthcareAgr o B io tech I n i t i a t i ves
Pro tec t i ng endangered he rbs
Techn ica l ass istan ce to fa rm ers
Cont r act cu l t i va t i on o f he rbs
Green House a t Nepa l
Dabu r i n t r oduced m ore t han 20 new p roduc t s / va r i an t s du r i ng FY11
A gronom y I n i t i a t i ves : Greenhouse a tDabur Nepa l & U t t a rancha l
Dabu r Research Faci l i t ies
99
7/31/2019 DIL Inv.presentation May 12
10/38
AgendaAgenda
Dabur India-Introduction
FMCG I nd us t r y Scenar io
Growth Strategy
Recent Performance
1010
7/31/2019 DIL Inv.presentation May 12
11/38
FMCG Industry SnapshotFMCG Industry Snapshot
FMCG I nd ust ry Size ( in Rs. bn) FMCG I n du st r y Ur ban ( i n Rs. b n) FMCG I n du st r y Ru r al ( in Rs. b n)
Source: AC Nielsen
FMCG sector in India continues on a strong growth path with both Urban and
Overv iew
. .
sales in India
Growth driven by increasing consumption led by rise in incomes, changinglifestyles and favorable demographics
As er a stud conducted b Booz & Com an FMCG sector is ex ected to row
1111
in the range of 12% to 17% upto 2020 and would touch a market size between ofRs. 4,000 to Rs. 6,200 billion
7/31/2019 DIL Inv.presentation May 12
12/38
Penetration Levels: Sufficient HeadroomPenetration Levels: Sufficient Headroom
77%80%
80%
90%
Rural Penetration Urban Penetration
67%
57%59%
50%
60%
70%
37%
18% 18%
32%
19%
26%
20%
30%
40%
3% 2%4%5%
0%
10%
Toothpaste Shampoo Hair Oil Skin Cream Mosquito
Repellants
Instant
Noodles
Hair Dyes Floor Cleaners
Source: Industry Data
Low penetration levels offer room for growth across consumption categories
1212
7/31/2019 DIL Inv.presentation May 12
13/38
Per Capita Consumption: Room for GrowthPer Capita Consumption: Room for Growth
9 3
Sk in Care Per Cap i ta Consum pt io n ( in US$) Sham poo Per Cap i t a Consump t ion ( i n US$)
in US$in US$
I n d i a h a s l o w p e r c ap i t a co n s u m p t i o n a s co m p a r e d t o o t h e r e m e r g i n g e c on o m i es
3.2
7.4 7.7
3
4
5
6
7
8
1.0 1.1
.2.4
1
1.5
2
2.5
0.80.3
0
1
2
China Indonesia India Malaysia Thailand
0.3
0
0.5
China Indonesia India Malaysia Thailand
2.9
2.5
3
3.5
Too thpas te Per Cap i t a Consump t ion ( i n US$)
in US$
0.5
1.0
0.4
.
0
0.5
1
1.5
2
1313
China Indonesia India Malaysia Thailand
Source: MOSL
7/31/2019 DIL Inv.presentation May 12
14/38
Key Players: FMCGKey Players: FMCG.
Com p an y Key Cat eg or ies Sales Pr o f i t Mar k et Cap
Hindu stan Un i lever LtdSoaps, Detergents,
1 9 6 ,9 1 0 2 2 ,9 6 1 8 2 6 ,4 4 5,
Nest l e I nd i a Ltd * Food, Beverages, Infantnutrition
7 4 ,9 0 8 9 ,6 1 5 4 2 8 ,0 8 7
Persona l , Hea l th &Hom ecare , Foods
, , ,
Godr e j Consum er Hair Care, Soaps 3 6 ,4 3 0 5 ,1 4 7 1 5 1 ,5 3 4
Co lga te Pa lmo l i ve ( I ) L t d * Oral Care & Toiletries 1 9 ,6 2 4 4 ,3 4 1 1 4 0 ,3 9 9
Glaxo Sm i th k l i n e Consum er* Consumer Health Care 2 6 ,8 5 5 3 ,5 5 2 1 0 9 ,1 7 7
Mar i co Ltd . Hair care, Food, Skincare 3 1 ,2 8 3 2 ,8 6 4 9 7 ,6 5 2
, , ,
Pr oc te r & Gamb le Hyg ieneand Hea l t h Care^
Feminine Hygiene,personal care
1 0 ,0 0 3 1 ,5 0 9 6 3 ,2 9 9
1414
Source: Published results for year ending 31.03.11
*Year ending 31.12.11
^Year ending 30.06.11
. ,
7/31/2019 DIL Inv.presentation May 12
15/38
Dabur: Strong Presence in FMCG CategoriesDabur: Strong Presence in FMCG Categories
Marke t Sha rePosi t ion Key Br an d sCategory
Dabur Amla hair Oil, Vatika hair oil &
Oral Car e
a a ampoos
13%3Red toothpaste, Babool, Meswak, Redtoothpowder
Ay urv ed i cTonics
Diges t i ves
67%1 Dabur Chyawanprash
56%1 Hajmola
Fr u i t Ju ices 52%1 Real Fruit Juices, Real Activ
Glucose 2 25% Dabur Glucose
1515
Sk in Car e(B leaches )
1 50% Fem
Hair care includes Hair Oils & Shampoos; Oral care includes Toothpastes & Toothpowder; Digestives includes herbal digestives
7/31/2019 DIL Inv.presentation May 12
16/38
AgendaAgenda
Dabur India-Introduction
FMCG Industry Scenario
Growth Strategy
Recent Performance
1616
7/31/2019 DIL Inv.presentation May 12
17/38
Business StructureBusiness Structure
Dabu r I n diaL im i t ed
Domest i c Bus iness( 6 9 .7 % )
I n t e r n a t i o n a lBu s in e ss ( 3 0 .3 % )
ConsumerCare
Foods( 1 0.1 % )
Reta i l( 0 .8 % )
DaburI n t e r n a t i o n a l
Hob iGroup
N a m a s t eLabs. LLC
Others*( 2 .7 % )
. . . .
1717
*OthersincludesCommodityExportsetc
Note: % figure in brackets indicate % share in Consolidated Sales for FY12
7/31/2019 DIL Inv.presentation May 12
18/38
Consumer Care OverviewConsumer Care Overview
Categor y-w ise Share o f Consum er Care Sa les
Health Supplements contribute to 22% of Consumer Care sales
Oral Care, comprising toothpastes and toothpowders contributes to 18% ofConsumer Care sales
1818
Note: Percentage share based on revenue for FY12
7/31/2019 DIL Inv.presentation May 12
19/38
Consumer Care CategoriesConsumer Care Categories
Key B rands
a r s
# 2 p la yer i n
Hai r Oi ls
Dabur Amla:Largest brand inthe portfolio
Vatika: Value addedcoconut oil
Anmol Hair Oil:Value proposition
Key B rand s
# 4 p la yer i nShampoos
1919
Vatika range of shampoos
7/31/2019 DIL Inv.presentation May 12
20/38
Consumer Care CategoriesConsumer Care Categories
Key B rands
# 3 p la yer i n
# 2 p la yer i nDabur Red: Toothpaste& Toothpowder
Babool: Targeted ateconomy segment
Meswak: Premiumtherapeutictoothpaste
To o t h p o w d e r
Key B rand s
p ay er nSkinL i gh ten ing
2020
Gulabari range of rosebased skin careproducts: Moisturizer,
Face freshener & Rosewater
Fem Gold Bleach:Launched recently
Uveda: Range ofAyurvedic SkinCare
7/31/2019 DIL Inv.presentation May 12
21/38
Consumer Care CategoriesConsumer Care Categories
Key B rands
Hom e Care
Fresheners
# 1 la er in
Odonil: Air freshner Odomos: Mosquito Sanifresh:
Mosqu i to Repe l lan tCreams
range: arges ranin the portfolio
repe an s n cream Toilet cleanerp ay er n o etCleaners
2121
7/31/2019 DIL Inv.presentation May 12
22/38
Consumer Care CategoriesConsumer Care Categories
Key B rands
ea t u p p em en t s
# 1 p l ay e r inA u rv ed ic Ton ics
# 2 p la y er i nGlucose
Dabur Chyawanprash:Largest selling healthsupplement in the
country
Dabur Glucose:2nd largest
player in thecountry
Dabur Honey: Largestbranded honey in thecountry; growing
category through replacesu ar strate
# 1 p l ay er i n
b ran ded Honey
Key B rands
Diges t i ves
# 1 p la y er i nHerba l
D iges t i ves
2222
Hajmola: Flagship brand
for branded Digestives
Hajmola tasty
digestive candy
7/31/2019 DIL Inv.presentation May 12
23/38
Consumer Care CategoriesConsumer Care Categories
an t ca s
Descr ip t i on
Repository of Daburs Ayurvedic HealthcareCHD St r uc tu re
Range of over 260 products
Focusing on multiple therapeutic areas. Distribution coverage of 200,000 chemists,
~12,000 vaidyas & 12,000 Ayurvedic
OTC ( 6 4 % )
Generics
ETHI CAL ( 36% )
Tonic
Focus on growing the OTC Health-Careportfolio aggressively
Branded Ethicals
OTC Healthcare is Rs.130 billion size industry
Expected to grow at 14-15% p.a. aspreference for Over-the-Counter productsaccelerates
Promoting Dabur Ayurveda: Generating
Dabur to expand its presence by : Consolidating / expanding current
portfolio
Launching new products in emerging
2323
Look at inorganic opportunities
Acquired the energizer brand, Thirty Plus
from Ajanta Pharma in May 2011
7/31/2019 DIL Inv.presentation May 12
24/38
Foods BusinessFoods Business
Foods portfolio comprises Juices and Culinary range
Juices are under the brands Real, Activ and Burrst
Culinary range is under Hommade brand
Foods
Foods business has surpassed the Rs. 5 billion mark in sales
Key B rands
# 1 p la yer i nFr u i t Ju ices
2424
ea : ags pbeverages brand
of 100% pure juice
7/31/2019 DIL Inv.presentation May 12
25/38
International BusinessInternational Business -
Exporter
Focus on Orderfulfillment throughIndia Mfg.
Dubai in 1989
Demand generationled to setting up ofmfg in Dubai & Egypt
International Ltd
Local operations further strengthened
Set up new mfg facilities in Nigeria,RAK& Bangladesh
.Consol. Sales
High Levels of Localization
Global Supply chain
1 9 8 0 s Ear ly 9 0 s 2 0 0 3 On w ar ds Tod ay
High l i gh t s
H ig h Gr o w t h i n I B D
4 7706,025
8,922
16,161
6000
8000
10000
12000
14000
16000
18000.
30% to consolidated sales led by CAGR of 32% in last 6 years
Focus markets:
GCC
.
1,281 1,8072,258 2,917
,
0
2000
4000
FY04 FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12
gyp
Nigeria
Turkey
Bangladesh
Ne al
U.S. High level of localization of manufacturing
and sales and marketing
Leveraging the Natural preference among
2525
care categories
Sustained investments in brand building and
marketing
7/31/2019 DIL Inv.presentation May 12
26/38
Africa and Middle East OverviewAfrica and Middle East Overview
Real GDP Gr ow t h Rat es ( YoY) in % Af r ica s Bu lg in g Base
Source: I MF Source: McKinsey on Afr ica, June 2010
Middle East and Africa have witnessed stable GDP growth rates
Between 2005 and 2015, it is estimated that in Africa, the share of individuals earningabove US$1,000 will grow from 39% to 55%.
The rapidly emerging African middle class could number as many as 300 million, out of a
2626
The sheer volumes and the growth in the number of aspirational consumers withdisposable income creates huge opportunities for consumer products companies
7/31/2019 DIL Inv.presentation May 12
27/38
Acquisition of Hobi Group, TurkeyAcquisition of Hobi Group, Turkey
Acquisition of Hobi Group, Turkey for a totalconsideration of US$ 69 Million completed onOctober 7, 2010
Hobi manufactures and markets hair, skin andbody care products under the brands Hobby
and New Era Product range of the company is
complementary to our product range
Acquisition provides an entry into anotherattractive emerging market and a goodplatform to leverage this across the region
2727
7/31/2019 DIL Inv.presentation May 12
28/38
Acquisition of Namaste LaboratoriesAcquisition of Namaste Laboratories
Dabur India Limited through its subsidiary Dabur International Limited acquired 100% stakein Namaste Laboratories LLC for $100 million, in an all-cash deal on January 1, 2011
Namast is a leading ethnic hair care products company, having products for women ofcolour, with revenues of c. $95 million (CY2010) from US, Europe, Middle East and African
The company markets a portfolio of hair care products under the brand Organic RootStimulator and has a strong presence in ethnic hair care market for women of colour.
Acquisition to enable entry into Ethnic Hair Care products market valued at more than US$1.5,
Bn) yet highly underpenetrated consumer markets of Sub Saharan Africa
We intend to grow the non U.S. business ahead of U.S. business and are taking initiatives inthis direction
2828
7/31/2019 DIL Inv.presentation May 12
29/38
AgendaAgenda
Dabur India-Introduction
FMCG Industry Scenario
Gr o w t h St r a t e g y
Recent Performance
2929
7/31/2019 DIL Inv.presentation May 12
30/38
Growth StrategyGrowth Strategy
Three p ronged Grow th St r a tegy
Expand I n n ov at e Acq u i r e
Our d i f f e ren t i a t i on i s t he h e rba l and ayu rved ic p lat f o r m
Expand
Strengthening presence in existing categories and markets as well entering new geographies
Maintain dominant share in categories where we are category builders like Health Supplements,Honey etc. and expand market shares in other categories
Calibrated international ex ansion local manufacturin and su l chain to enhance flexibilit/ reduce response time to change in market demands
I n n o v a t e
Strong focus on innovation. Have rolled out new variants & products which have contributed toaround 5-6% of our rowth .a.
Renovation of existing products to respond to changing demands (Toothpowder to Toothpaste)
Acqu i re
Acquisitions critical for building scale in existing categories & markets
3030
Should be synergistic and make a good strategic fit
Target opportunities in our focus markets
7/31/2019 DIL Inv.presentation May 12
31/38
AgendaAgenda
Dabur India-Introduction
FMCG Industry Scenario
Growth Strategy
Recen t Per fo r m ance
3131
7/31/2019 DIL Inv.presentation May 12
32/38
Recent Financial PerformanceRecent Financial Performance
onso a e a es grew y . ur ngQ4FY12.
Sales growth was a combination of volume
growth and price increases and marginalRevenue
(inRs.Cr.)translation gains
Volume growth was at 12.4%
EBITDA
inRs.Cr.
ncrease y 4.2% w e marg nwas lower at 17.8% in Q4FY12 v/s 21.1% inQ4FY11
Material costs were at 50.2% of sales vis
vis 47% in
Adpro during the quarter increased to 13.4% ascompared to 11.5% in previous year
PAT
Consolidated PAT reported growth of 16.0%
This was despite severe input costpressure and increase in advertising andromotional costs
3232
7/31/2019 DIL Inv.presentation May 12
33/38
Stock Performance & Shareholding PatternStock Performance & Shareholding Pattern
Shareho ld ing St ru c tu re*Market Cap i ta l i za t ion in Rs. b i l l i on
174200
17
*As on March 31, 2012
2001 20112012
D ab u r r a n k ed a s t h e o r a n iz at i o n t h at o f f er s t h e b es t r et u r n t o i n v e st o r s bthe 6 th Soc ia l & Cor po r a t e Gover nance Aw ar ds , p r esen ted b y t he Bom bay
Stock Exchan ge
3333
7/31/2019 DIL Inv.presentation May 12
34/38
Consolidated P&LConsolidated P&L
n
s.crores o
o
NetSales 1363.6 1108.2 23.0% 5,283.2 4,077.4 29.6%
OtherOperatingIncome 9.0 5.9 53.7% 22.2 27.1 17.9%
MaterialCost 684.9 521.3 31.4% 2,685.2 1,937.5 38.6%
%ofSales 50.2% 47.0% 50.8% 47.5%EmployeeCosts 95.6 87.3 9.6% 387.4 308.7 25.5%
%ofSales 7.0% 7.9% 7.3% 7.6%AdPro 182.0 127.4 42.9% 659.5 534.6 23.4%
%ofSales 13.4% 11.5% 12.5% 13.1%OtherExpenses 185.7 161.0 15.4% 683.1 522.5 30.7%
%ofSales 13.6% 14.5% 12.9% 12.8%Other
Non
Operating
Income 19.0 16.3 16.7% 57.4 32.1 78.6%
EBITDA 243.3 233.4 4.2% 947.6 833.4 13.7%
%ofSales 17.8% 21.1% 17.9% 20.4%InterestExp.andFin.Charges 5.7 15.9 53.8 30.3
De reciation + Amortization 29.3 29.1 103.2 95.2
ProfitBefore
Tax
(PBT) 208.3 188.4 10.5% 790.5 707.9 11.7%
TaxExpenses 37.7 41.4 8.9% 146.4 139.0 5.3%
PAT(AfterexceptionalItems) 170.5 147.0 16.0% 644.1 568.9 13.2%
3434
nor y n eres ro oss . . . .
PAT(AfterExtraordinaryitem&MinorityInt) 170.5 147.0 16.0% 644.9 568.6 13.4%
%ofSales 12.5% 13.3% 12.2% 13.9%
7/31/2019 DIL Inv.presentation May 12
35/38
Consolidated Statement of Assets and LiabilitiesConsolidated Statement of Assets and LiabilitiesAs at As at
Particulars (in Rs. crores) (current year end)31/03/2012
(previous year end)31/03/2011
A EQUITY AND LIABILITIES1 Shareholders funds
(a) Share capital 174 174(b) Reserves and surplus 1,543 1,217(c) Money received against share warrants - -Sub-total - Shareholders' funds 1,717 1,391
2 Share application money pending allotment3 Minority interest * 3 44 Non-current liabilities
(a) Long-term borrowings 727 717(b) Deferred tax liabilities (net) 27 19(c) Other long-term liabilities - -(d) Long-term provisions 658 578Sub-total - Non-current liabilities 1,412 1,314
5 Current liabilities(a) Short-term borrowings 347 303(b) Trade payables 859 661
(c) Other current liabilities 120 109(d) Short-term provisions 164 141Sub-total - Current liabilities 1,490 1,214
TOTAL - EQUITY AND LIABILITIES 4,622 3,923B ASSETS1 Non-current assets
(a) Fixed assets 869 732(b) Goodwill on consolidation * 799 799(c) Non-current investments 89 2(d) Deferred tax assets (net) - -
(e) Long-term loans and advances 433 340(f) Other non-current assets 72 101Sub-total - Non-current assets 2,262 1,974
2 Current assets(a) Current investments 393 418(b) Inventories 824 709
3535
(c) Trade receivables 462 355(d) Cash and cash equivalents 448 280(e) Short-term loans and advances 154 127(f) Other current assets 79 60
Sub-total - Current assets 2,360 1,949TOTAL - ASSETS 4,622 3,923
7/31/2019 DIL Inv.presentation May 12
36/38
Recent AccoladesRecent Accolades
D ab u r h a s b e en v o t e d b yconsum ers as I nd i an
D ab u r r a n k e d a s N o .2 Most Soc ia l Brando f I n d i a i n t h e So ci a l
D ab u r I n d i a L t d h as b ee nranked am on g t he Top 10
D a bu r h a s b e en r a n k e das the Most Trust ed
- ,M ed ia repo r tlaunched a t C l i ckAs ia Sum m i t 2012
Fo r i n t he M anu f ac t u r i ngsector by Bus in ess Today
ca t ego ry i n t he BrandT rus t Repo r t 201 2
D ab u r ' s g r e en f ie ld u n i t i nBadd i aw arded LEEDI nd ia Si l ve r Ra t i ng f o r
D ab u r ' s B ad d i U ni t saw arded S i l verCer t i f i ca t ion fo r
D ab u r r a n k ed 3 7 i nl i s t o f I nd i a ' sGreatest Weal thCreator s 2011. Dabur
D ab u r r a n k ed 1 8 4 i nth e FE-50 0 l i s t o fI nd ia 's Finest
3636
S t anda rds
Enhanc ing M anu f act u r i ng& Supp ly Cha inExce l lence, by ETI nd iaM anu f ac t u r i ng
Excel len ce cel l
has been rank ed 30in t he l i st o f I nd i a ' sTop Em p loym en tGenera t ors by
Bus iness & Econom ym agaz ine
7/31/2019 DIL Inv.presentation May 12
37/38
DisclaimerDisclaimer
Some of the statements made in this presentation contain forward looking information that involve a
. , ,
projections or plans that are inherently subject to significant risks, as well as uncertainties and
contingencies that are subject to change. Actual results can differ materially from those anticipated in theCompanys forwardlooking statements as a result of a variety of factors, including those set forth fromtime to time in the Companys press releases and reports and those set forth from time to time in theCompanys analyst calls and discussions. We do not assume any obligation to update the forwardlookingstatements contained in this presentation.
No part of this presentation shall form the basis of or may be relied upon in connection with any contract
or commitment. This presentation is being presented solely for your information and is subject to change
without notice.
3737
7/31/2019 DIL Inv.presentation May 12
38/38
Investor RelationsDabur India Ltd
Contact:+91-11-42786000
3838